Asan Medical Center / 서울아산병원
Hospital
Location:
Seoul,
Korea, Republic of (KR)
ISNI: 0000000108422126
ROR: https://ror.org/03s5q0090
Show on Map:
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial (2021)
Rugo HS, Im SA, Cardoso F, Cortes J, Curigliano G, Musolino A, Pegram MD, et al.
Journal article
Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study (2019)
Feagan BG, Sandborn WJ, D'Haens GR, Panes J, Kaser A, Ferrante M, Louis E, et al.
Conference contribution
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study (2018)
Feagan BG, Panes J, Ferrante M, Kaser A, D'Haens GR, Sandborn WJ, Louis E, et al.
Journal article
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study (2017)
Feagan BG, Sandborn WJ, D'Haens G, Panes J, Kaser A, Ferrante M, Louis E, et al.
Journal article
Comparison between core-lab and site-read assessment of coronary CT angiography for detection of ischemia-causing lesions: a substudy of the NXT trial (2016)
Marwan M, Gaur S, Leipsic J, Seneviratne S, Ito H, Mauri L, De Bruyne B, et al.
Conference contribution